MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/den.14711

Медицинская библиотека · Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2023

Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.

Inoue Haruhiro, Yamamoto Kazuki, Shimamura Yuto, Azuma Daisuke, Ushikubo Kei, Okada Hiroki, Kimoto Yoshiaki, Nishikawa Yohei, Tanaka Ippei, Tanabe Mayo, Onimaru Manabu, Navarro Marc Julius

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Anti-reflux mucosectomy (ARMS) and anti-reflux mucosal ablation (ARMA) were developed as interventions for proton pump inhibitor (PPI)-refractory/-dependent gastroesophageal reflux disease (GERD). Although ARMS and ARMA are established treatments for PPI-refractory GERD, reliance on natural healing for ulcer scar formation introduces uncertainty and bleeding risk. To address these issues, we introduced a novel approach called anti-reflux mucoplasty (ARM-P), which involves immediate closure of mucosal defects following mucosectomy. This pilot study aims to evaluate the safety, feasibility, and efficacy of ARM-P.

METHODS

A retrospective single-center study was conducted using prospectively collected data from October 2022 to July 2023. Patients with PPI-refractory/-dependent GERD who underwent ARM-P were included. The study evaluated technical success of ARM-P, before and after ARM-P GERD-Health Related Quality of Life Questionnaire, GerdQ, and Frequency Scale for the Symptoms of GERD scores, along with PPI discontinuation and endoscopic esophagogastric junction morphology.

RESULTS

A total of 20 patients with a median age of 61.5 years underwent the ARM-P procedure. The procedure achieved 100% technical success without adverse events. After ARM-P, 55.0% discontinued PPI usage and 15.0% reduced PPI dose by half. Median GERD-Health Related Quality of Life Questionnaire score improved from 21 to 6 (P = 0.0026), median GerdQ score improved from 9 to 7 (P = 0.0022), and median Frequency Scale for the Symptoms of GERD score decreased from 16 to 7 (P = 0.0003). Median Hill's Classification significantly improved from grade III to grade I (P = 0.0001).

CONCLUSIONS

This study presents the first pilot report of ARM-P, demonstrating its procedural safety, technical feasibility, and short-term efficacy.

Для цитирования: Inoue Haruhiro, Yamamoto Kazuki, Shimamura Yuto, Azuma Daisuke, Ushikubo Kei, Okada Hiroki, Kimoto Yoshiaki, Nishikawa Yohei, Tanaka Ippei, Tanabe Mayo, Onimaru Manabu, Navarro Marc Julius. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2023. DOI: 10.1111/den.14711.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.